JP2015521467A5 - - Google Patents

Download PDF

Info

Publication number
JP2015521467A5
JP2015521467A5 JP2015517226A JP2015517226A JP2015521467A5 JP 2015521467 A5 JP2015521467 A5 JP 2015521467A5 JP 2015517226 A JP2015517226 A JP 2015517226A JP 2015517226 A JP2015517226 A JP 2015517226A JP 2015521467 A5 JP2015521467 A5 JP 2015521467A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
sequence represented
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015517226A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015521467A (ja
JP5807994B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/042552 external-priority patent/WO2013187906A1/en
Publication of JP2015521467A publication Critical patent/JP2015521467A/ja
Publication of JP2015521467A5 publication Critical patent/JP2015521467A5/ja
Application granted granted Critical
Publication of JP5807994B2 publication Critical patent/JP5807994B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015517226A 2012-06-15 2012-06-15 アレルギー治療のための核酸 Active JP5807994B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2012/042552 WO2013187906A1 (en) 2012-06-15 2012-06-15 Nucleic acids for treatment of allergies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015119893A Division JP6088584B2 (ja) 2015-06-15 2015-06-15 アレルギー治療のための核酸

Publications (3)

Publication Number Publication Date
JP2015521467A JP2015521467A (ja) 2015-07-30
JP2015521467A5 true JP2015521467A5 (enExample) 2015-09-10
JP5807994B2 JP5807994B2 (ja) 2015-11-10

Family

ID=49758576

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015517226A Active JP5807994B2 (ja) 2012-06-15 2012-06-15 アレルギー治療のための核酸

Country Status (20)

Country Link
US (3) US9744230B2 (enExample)
EP (2) EP3808361A1 (enExample)
JP (1) JP5807994B2 (enExample)
KR (2) KR102107646B1 (enExample)
CN (2) CN107937423A (enExample)
AU (3) AU2012382406B2 (enExample)
BR (1) BR112014031327B1 (enExample)
CA (1) CA2876824C (enExample)
CY (1) CY1123769T1 (enExample)
DK (1) DK2861240T3 (enExample)
ES (1) ES2831723T3 (enExample)
HR (1) HRP20201815T1 (enExample)
HU (1) HUE052481T2 (enExample)
IL (4) IL236174B (enExample)
LT (1) LT2861240T (enExample)
PL (1) PL2861240T3 (enExample)
PT (1) PT2861240T (enExample)
RS (1) RS61098B1 (enExample)
SI (1) SI2861240T1 (enExample)
WO (1) WO2013187906A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160185831A1 (en) * 2011-06-14 2016-06-30 Immunomic Therapeutics, Inc. Nucleic acids for treatment of allergies
PL2861240T3 (pl) * 2012-06-15 2021-07-05 Immunomic Therapeutics, Inc. Kwasy nukleinowe do leczenia alergii
NZ707615A (en) 2012-10-30 2019-01-25 Aravax Pty Ltd Novel immunotherapeutic molecules and uses thereof
WO2015042664A1 (en) 2013-09-25 2015-04-02 Monash University Novel immunotherapeutic composition and uses thereof
EP3157558A2 (en) * 2014-06-23 2017-04-26 Immunomic Therapeutics, Inc. Nucleic acids for treatment of peanut allergies
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
TWI752930B (zh) 2015-12-23 2022-01-21 德商梅迪基因免疫治療公司 抗原特異性tcr的新生成
CN110418650A (zh) * 2016-11-16 2019-11-05 免疫治疗有限公司 用于治疗过敏的核酸
EP3612556B8 (en) * 2017-04-22 2024-11-20 Immunomic Therapeutics, Inc. Improved lamp constructs
WO2018204534A1 (en) * 2017-05-02 2018-11-08 Immunomic Therapeutics, Inc. Lamp (lysosomal associated membrane protein) constructs comprising cancer antigens
CN111465328A (zh) 2017-07-18 2020-07-28 前品牌股份有限公司 制备混合型变应原组合物的方法
EP3779443A4 (en) * 2018-04-06 2022-05-04 Slsbio Co., Ltd. NEW IMMUNOGLOBULIN E EPITOPE, BINDING ANTIBODY AND KIT FOR THE ANALYSIS OF IMMUNOGLOBULIN E IN A SAMPLE CONTAINING IT
WO2019216394A1 (ja) * 2018-05-11 2019-11-14 アステラス製薬株式会社 ダニアレルギー治療のための核酸
CA3099505A1 (en) * 2018-05-11 2019-11-14 Astellas Pharma Inc. Nucleic acid for treating crustacean allergy
JP2021523185A (ja) 2018-05-15 2021-09-02 イミュノミック セラピューティックス, インコーポレイテッドImmunomic Therapeutics, Inc. アレルゲンを含む改善されたlamp構築物
US11766477B2 (en) 2019-01-23 2023-09-26 Societe Des Produits Nestle S.A. Methods for making mixed allergen compositions
CN113631231A (zh) * 2019-03-13 2021-11-09 普梭梅根公司 用于过敏治疗的基于表位的方法和克罗恩病的抑制剂
KR20220083773A (ko) 2019-10-18 2022-06-20 이뮤노믹 쎄라퓨틱스, 인크. 암 항원을 포함하는 개선된 lamp 구축물
JP2024517463A (ja) * 2021-05-04 2024-04-22 ソヴィダ ソリューションズ リミテッド ニコチンアミドアデニンジヌクレオチド(nad)組成物、それらの製造方法、及びそれらの使用方法
CN117795081A (zh) * 2021-08-06 2024-03-29 花王株式会社 利用snare的核酸构建体
FI131854B1 (en) 2023-05-29 2026-01-12 Onni Biotechnologies Oy Modified natural killer cells with enhanced cytotoxic activity and greater survival

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD335810S (en) 1990-07-02 1993-05-25 Dick-Ming Asien Handle for luggage or similar article
US6982326B1 (en) 1991-07-12 2006-01-03 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from Japanese cedar pollen
US6090386A (en) 1991-07-12 2000-07-18 Griffith; Irwin J. T cell peptides of the CRX JII allergen
WO1994024281A1 (en) * 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
AU5668194A (en) * 1992-11-12 1994-06-08 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from japanese cedar pollen
US5633234A (en) 1993-01-22 1997-05-27 The Johns Hopkins University Lysosomal targeting of immunogens
JP3649460B2 (ja) 1993-11-05 2005-05-18 明治乳業株式会社 スギ花粉アレルゲンCry j IIエピトープ
GB9516760D0 (en) 1995-08-16 1995-10-18 Sandoz Ltd Organic compounds
CA2241918C (en) 1995-12-29 2008-12-02 University Of Arkansas Peanut allergens and methods
CA2258125C (en) 1996-06-14 2010-11-23 Meiji Milk Products Co., Ltd. T-cell epitope peptides
US20020142978A1 (en) * 2000-04-07 2002-10-03 Eyal Raz Synergistic improvements to polynucleotide vaccines
WO2002074250A2 (en) 2001-03-16 2002-09-26 Panacea Pharmaceuticals Methods and reagents for decreasing clinical reaction to allergy
ES2404689T3 (es) * 2001-04-05 2013-05-28 The Johns Hopkins University Vacunas quiméricas que comprenden el dominio lumenal de LAMP-1 o LAMP-2
US20060003148A1 (en) 2004-06-30 2006-01-05 Zwynenburg James L Interlocking polymeric foam floor underlayment and process for making
US20060216315A1 (en) * 2005-03-16 2006-09-28 Yoo Tai J Cockroach allergen gene expression and delivery systems and uses
US20090304738A1 (en) 2005-06-16 2009-12-10 Moran Thomas M Methods for Enhancing Immune Responses
US7566456B2 (en) 2005-06-23 2009-07-28 Haiming Chen Allergen vaccine proteins for the treatment and prevention of allergic diseases
WO2007024026A1 (ja) * 2005-08-25 2007-03-01 Taiho Pharmaceutical Co., Ltd. T細胞認識エピトープペプチドを固定化又は内包化した生分解性ナノ粒子
US20080006554A1 (en) 2006-07-07 2008-01-10 Medtronic Vascular, Inc. Packaging assembly for a catheter
EP2042193A1 (en) * 2007-09-28 2009-04-01 Biomay AG RNA Vaccines
EP2331568B1 (en) * 2008-09-10 2014-09-03 ITH Immune Therapy Holdings AB Treating inflammatory conditions
PL2861240T3 (pl) * 2012-06-15 2021-07-05 Immunomic Therapeutics, Inc. Kwasy nukleinowe do leczenia alergii
CN110418650A (zh) * 2016-11-16 2019-11-05 免疫治疗有限公司 用于治疗过敏的核酸
EP3612556B8 (en) * 2017-04-22 2024-11-20 Immunomic Therapeutics, Inc. Improved lamp constructs

Similar Documents

Publication Publication Date Title
CN111560074B (zh) 一种基于幽门螺旋杆菌铁蛋白的新型冠状病毒s蛋白单区域亚单位纳米疫苗
JP5807994B2 (ja) アレルギー治療のための核酸
JP6874031B2 (ja) アイメリアに対する免疫応答を強化するか又はアイメリア感染症を制限する組成物及び方法
RU2630652C2 (ru) Гибридные белки-носители пептидов в качестве вакцин от аллергии
EP2924047B1 (en) Vaccine carrier
JP2017521064A5 (enExample)
CN108136000B (zh) 经改良的模块化抗原转运分子及其在动物中的用途
CN113454102A (zh) 非洲猪瘟疫苗
US20110150920A1 (en) Allergy Vaccines Containing Hybrid Polypeptides
CN106132996B (zh) 经改良的模块化抗原转运分子及其用途
KR20150130480A (ko) 장내 병원균에 대한 면역 반응을 증진시키는 조성물 및 방법
WO2023023940A1 (zh) 一种诱导广谱抗冠状病毒的t细胞疫苗免疫原及其应用
KR102871378B1 (ko) 비정상적인 il-4 및/또는 il-13 발현 또는 활성과 관련된 장애를 치료하기 위한 il-4 및/또는 il-13을 포함하는 면역원성 생성물
JP2008521837A5 (enExample)
JP6353510B2 (ja) アレルギー治療のための核酸
JP2008500802A5 (enExample)
CN101880328A (zh) 微小隐孢子虫Th多表位基因和融合蛋白及其应用
TW202003542A (zh) 用於塵蟎過敏治療之核酸
JP6088584B2 (ja) アレルギー治療のための核酸
CN104971362B (zh) 一种登革病毒通用型ctl表位dna疫苗制备和应用
CN120943970A (zh) FcRn靶向的布鲁氏菌多表位纳米疫苗、其制备方法及其应用
AU2014352986A1 (en) Pan pollen immunogens and methods and uses thereof for immune response modulation
CA3259522A1 (en) ALLERGY VACCINES BASED ON ALLERGENS CONSENSUS
EA041116B1 (ru) Улучшенные транспортные молекулы модулярного антигена и их применение у животных